miR-146a Suppresses Invasion of Pancreatic Cancer Cells
- 14 February 2010
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (4), 1486-1495
- https://doi.org/10.1158/0008-5472.can-09-2792
Abstract
The aggressive course of pancreatic cancer is believed to reflect its unusually invasive and metastatic nature, which is associated with epidermal growth factor receptor (EGFR) overexpression and NF-κB activation. MicroRNAs (miRNA) have been implicated in the regulation of various pathobiological processes in cancer, including metastasis in pancreatic cancer and in other human malignancies. In this study, we report lower expression of miR-146a in pancreatic cancer cells compared with normal human pancreatic duct epithelial cells. Reexpression of miR-146a inhibited the invasive capacity of pancreatic cancer cells with concomitant downregulation of EGFR and the NF-κB regulatory kinase interleukin 1 receptor–associated kinase 1 (IRAK-1). Cellular mechanism studies revealed crosstalk between EGFR, IRAK-1, IκBα, NF-κB, and MTA-2, a transcription factor that regulates metastasis. Treatment of pancreatic cancer cells with the natural products 3,3′-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-κB, resulting in an inhibition of pancreatic cancer cell invasion. Our findings reveal DIM and isoflavone as nontoxic activators of a miRNA that can block pancreatic cancer cell invasion and metastasis, offering starting points to design novel anticancer agents. Cancer Res; 70(4); 1486–95Keywords
This publication has 42 references indexed in Scilit:
- Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer CellsCancer Research, 2009
- Breast cancer metastasis suppressor 1 coordinately regulates metastasis‐associated microRNA expressionInternational Journal of Cancer, 2009
- Modulation of CXCR4, CXCL12, and Tumor Cell Invasion Potential In Vitro by PhytochemicalsJournal of Oncology, 2009
- Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell GrowthPLOS ONE, 2008
- Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cellsOncogene, 2008
- Loss of mir-146a function in hormone-refractory prostate cancerRNA, 2008
- miRBase: tools for microRNA genomicsNucleic Acids Research, 2007
- Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor developmentProceedings of the National Academy of Sciences, 2007
- NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responsesProceedings of the National Academy of Sciences, 2006
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005